Source: Health Products Regulatory Authority (IE) Revision Year: 2018 Publisher: Merus Labs Luxco II S.à.R.L., 26-28 rue Edward Steichen, L-2540, Luxembourg
Nitrocine 1 mg/ml solution for infusion, vial.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear colourless and odourless isotonic sterile solution. |
Each vial contains 50 mg glyceryl trinitrate in 50 ml (1mg/ml).
For a full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Glyceryl trinitrate |
Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache. |
| List of Excipients |
|---|
|
Glucose |
Clear glass (type II) vials with rubber closure (Bromobutyl polymer) and aluminium cap containing 50ml. The vials are packed singly in an outer carton.
Not all pack sizes may be marketed.
Merus Labs Luxco II S.à.R.L., 26-28 rue Edward Steichen, L-2540, Luxembourg
PA2118/001/002
Date of first authorisation: 2 August 1983
Date of last renewal: 23 May 2008
| Drug | Countries | |
|---|---|---|
| NITROCINE | Estonia, Lithuania, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
